These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20307901)

  • 1. Association between reduced ADAMTS13 and diabetic nephropathy.
    Taniguchi S; Hashiguchi T; Ono T; Takenouchi K; Nakayama K; Kawano T; Kato K; Matsushita R; Nagatomo M; Nakamura S; Nakashima T; Maruyama I
    Thromb Res; 2010 Jun; 125(6):e310-6. PubMed ID: 20307901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
    Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
    Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
    Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
    Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.
    Skeppholm M; Kallner A; Kalani M; Jörneskog G; Blombäck M; Wallén HN
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):619-26. PubMed ID: 19809308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
    Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
    Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
    Domingueti CP; Dusse LM; Fóscolo RB; Reis JS; Annichino-Bizzacchi JM; Orsi FL; Mazetto Bde M; Carvalho Md; Gomes KB; Fernandes AP
    PLoS One; 2015; 10(7):e0132784. PubMed ID: 26168189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.
    Rurali E; Noris M; Chianca A; Donadelli R; Banterla F; Galbusera M; Gherardi G; Gastoldi S; Parvanova A; Iliev I; Bossi A; Haefliger C; Trevisan R; Remuzzi G; Ruggenenti P;
    Diabetes; 2013 Oct; 62(10):3599-609. PubMed ID: 23733198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
    Lacquemant C; Gaucher C; Delorme C; Chatellier G; Gallois Y; Rodier M; Passa P; Balkau B; Mazurier C; Marre M; Froguel P
    Kidney Int; 2000 Apr; 57(4):1437-43. PubMed ID: 10760079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
    Fuchigami S; Kaikita K; Soejima K; Matsukawa M; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Nakagaki T; Sugiyama S; Ogawa H
    Thromb Res; 2008; 122(5):618-23. PubMed ID: 18295305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients.
    Allie S; Stanley A; Bryer A; Meiring M; Combrinck MI
    Int J Stroke; 2015 Dec; 10(8):1294-6. PubMed ID: 26121272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).
    Kobayashi T; Wada H; Nishioka N; Yamamoto M; Matsumoto T; Tamaru T; Nomura S; Masuya M; Mori Y; Nakatani K; Nishikawa M; Katayama N; Nobori T
    Thromb Res; 2008; 121(6):849-54. PubMed ID: 17900666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
    Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
    Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.
    Domingueti CP; Fóscolo RB; Reis JS; Campos FM; Dusse LM; Carvalho Md; Braga Gomes K; Fernandes AP
    J Diabetes Res; 2016; 2016():2315260. PubMed ID: 26770985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
    Löwenberg EC; Charunwatthana P; Cohen S; van den Born BJ; Meijers JC; Yunus EB; Hassan MU; Hoque G; Maude RJ; Nuchsongsin F; Levi M; Dondorp AM
    Thromb Haemost; 2010 Jan; 103(1):181-7. PubMed ID: 20062916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.